Opioid Use in Medicare Part D in 2022: Annual Review
The opioid crisis remains a public health emergency. In 2021, an estimated 82,310 opioid-related overdose deaths occurred in the United States. Identifying patients who are at risk for overdose or abuse is key to addressing this crisis. This data brief, Opioid Use in Medicare Part D in 2022: Annual Review, builds on our series of annual reports and provides information on opioid utilization among people enrolled in Medicare Part D in 2022. It provides 2022 data on the number of enrollees who received extreme amounts of opioids through Part D and those who appeared to be doctor shopping. It also identifies prescribers who ordered opioids for large numbers of these enrollees. In addition, the brief provides data on the number of enrollees who received drugs to treat opioid use disorder, the number of enrollees who experienced an opioid overdose, and the number of enrollees who received opioid overdose-reversal drugs.
|Announced or Revised||Agency||Title||Component||Report Number(s)||Expected Issue Date (FY)|
|May 2023||Centers for Medicare and Medicaid Services||Opioid Use in Medicare Part D in 2022: Annual Review||Office of Evaluation and Inspections||OEI-02-23-00250||2023|